Immediate Impact

5 by Nobel laureates 3 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis
2023 Standout
Cancer Statistics, 2021
2021 Standout
29 intermediate papers

Works of Carlo Donada being referenced

Long-term clinical outcome after beta-interferon therapy in cirrhotic patients with chronic hepatitis C. TVVH Study Group.
2000
Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
2000
and 4 more

Author Peers

Author Last Decade Papers Cites
Carlo Donada 898 757 210 278 25 1.0k
P. Grippon 948 717 299 187 40 1.3k
P. Muratori 915 805 350 222 22 1.2k
Paolo Montalto 667 485 94 307 17 877
Luigi Iannaccone 558 368 302 349 30 1.1k
Jean‐Michel Métreau 889 705 110 411 31 1.3k
Harlan I. Wright 838 760 79 519 24 1.3k
E. Zuckerman 631 542 224 208 30 1.0k
Michaël Bismuth 595 546 56 347 38 1.1k
Claudio Puoti 930 822 66 125 40 1.0k
Birgit Terjung 519 418 153 296 31 917

All Works

Loading papers...

Rankless by CCL
2026